Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

99 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
The health-related quality of life of sarcoma patients treated with neoadjuvant versus adjuvant radiotherapy - Results of a multi-center observational study.
Singer S, Semrau S, Golcher H, Fechner K, Kallies A, Zapata Bonilla S, Grützmann R, Fietkau R, Kluba T, Jentsch C, Andreou D, Bornhäuser M, Schmitt J, Schuler MK, Eichler M. Singer S, et al. Among authors: fechner k. Radiother Oncol. 2023 Dec;189:109913. doi: 10.1016/j.radonc.2023.109913. Epub 2023 Sep 21. Radiother Oncol. 2023. PMID: 37739319 Free article.
Chemoradiotherapy plus hyperthermia (CRTH) versus chemoradiotherapy (CRT) alone in neoadjuvant treatment of soft tissue sarcoma: tumor response, treatment toxicity and disease control.
Willner A, Agaimy A, Fechner K, Ott O, Denz A, Weissmann T, Meidenbauer N, Höfler D, Gaipl U, Frey B, Schmidt M, Haller F, Horch R, Hartmann A, Grützmann R, Fietkau R, Semrau S. Willner A, et al. Among authors: fechner k. Int J Hyperthermia. 2023;40(1):2248424. doi: 10.1080/02656736.2023.2248424. Int J Hyperthermia. 2023. PMID: 37611915 Free article.
Neoadjuvant concurrent chemoradiotherapy with and without hyperthermia in retroperitoneal sarcomas: feasibility, efficacy, toxicity, and long-term outcome.
Willner A, Fechner K, Agaimy A, Haller F, Eckstein M, Ott OJ, Putz F, Gaipl US, Kersting S, Meidenbauer N, Grützmann R, Fietkau R, Semrau S. Willner A, et al. Among authors: fechner k. Strahlenther Onkol. 2021 Dec;197(12):1063-1071. doi: 10.1007/s00066-021-01830-0. Epub 2021 Nov 4. Strahlenther Onkol. 2021. PMID: 34735576 Free PMC article.
Watch and wait after neoadjuvant treatment in rectal cancer: comparison of outcomes in patients with and without a complete response at first reassessment in the International Watch & Wait Database (IWWD).
Temmink SJD, Peeters KCMJ, Bahadoer RR, Kranenbarg EM, Roodvoets AGH, Melenhorst J, Burger JWA, Wolthuis A, Renehan AG, Figueiredo NL, Pares O, Martling A, Perez RO, Beets GL, van de Velde CJH, Nilsson PJ; International Watch & Wait Database (IWWD) Consortium. Temmink SJD, et al. Br J Surg. 2023 May 16;110(6):676-684. doi: 10.1093/bjs/znad051. Br J Surg. 2023. PMID: 36972213 Free PMC article.
Serum reactivity in dermatitis herpetiformis: an international multicentre study.
Boch K, Heck F, Hammers CM, Antiga E, Caproni M, Juhl D, Goletz S, Horváth ON, Huilaja L, Khil'chenko S, Sina C, Tasanen K, Vassileva S, Schlumberger W, Zillikens D, Shahid M, Drenovska K, Zone JJ, Koszorú K, Fechner K, Dähnrich C, König IR, Schmidt E. Boch K, et al. Among authors: fechner k. Clin Exp Dermatol. 2023 Dec 19;49(1):53-57. doi: 10.1093/ced/llad319. Clin Exp Dermatol. 2023. PMID: 37793183
99 results